文献速递妇科产科

宫颈癌保育手术趋势:根治性子宫颈切除术使用下降

Trachelectomy in decline: national trends, outcomes, and academic output across 3 major databases.
PubMed 文献 · Am J Obstet Gynecol · 2026-03-04

本研究整合美国国家癌症数据库(2004-2022)、NSQIP(2012-2022)和Web of Science(2000-2025)三个数据库,回顾分析18-45岁宫颈癌患者接受子宫颈切除术或锥切术的趋势与结局。结果显示子宫颈切除术比例从2011年64.0%降至2022年33.3%(P<.001),两组10年总生存相似(93.4% vs 92.3%,P=.39),文献发表量2021年达峰后下降。

要点

  • 子宫颈切除术使用比例从2011年64.0%持续下降至2022年33.3%。
  • 子宫颈切除术与锥切术10年总生存相似(93.4% vs 92.3%)。
  • 子宫颈切除术相关文献发表量2021年达峰后下降。

核心结论

  • 近年子宫颈切除术使用显著减少,两种保育手术后总生存均较高,实践模式正转向更少根治性的手术。

研究设计与样本

  • 回顾性研究,整合美国国家癌症数据库(2004-2022)临床数据、NSQIP(2012-2022)围手术期结局和Web of Science(2000-2025)文献计量数据。
  • 国家癌症数据库纳入18-45岁宫颈癌患者,均接受保守手术及淋巴结评估,分为子宫颈切除术组和锥切术组。

主要发现

  • 共1841例患者接受保守手术加淋巴结评估,其中子宫颈切除术911例(49.5%),锥切术930例(50.5%)。
  • 子宫颈切除术组患者较锥切术组年轻(中位31岁 vs 33岁,P<.001),淋巴结检出数更多(15 vs 10,P<.001)。
  • 子宫颈切除术组鳞癌比例较低(51.0% vs 61.3%),腺癌比例较高(40.7% vs 35.2%)(P<.001)。
  • 子宫颈切除术比例从2011年64.0%降至2022年33.3%(P<.001)。
  • 两组10年总生存相似(93.4% vs 92.3%,log-rank P=.39),Cox回归显示子宫颈切除术与总生存无关(HR 1.02,95%CI 0.56-1.86)。

关键数值与推荐

  • 子宫颈切除术比例2011年64.0%,2022年33.3%(P<.001)。
  • 10年总生存:子宫颈切除术组93.4%,锥切术组92.3%(log-rank P=.39)。
  • 多因素Cox回归HR 1.02(95%CI 0.56-1.86)。
  • 文献计量分析共1585篇子宫颈切除术相关文献,2021年峰值128篇,原创研究占58.0%,综述占15.6%。

临床怎么用

  • 对于低风险宫颈癌年轻患者,锥切术可作为子宫颈切除术的替代保育手术,两者总生存相似。
  • 临床决策中应结合肿瘤病理特征(如鳞癌/腺癌比例差异)个体化选择保育手术方式。

局限性

  • 回顾性研究设计,存在选择偏倚可能。
  • 子宫颈切除术组未指定根治性程度。
  • 国家癌症数据库缺乏复发和疾病特异性生存数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In 2021, the ConCerv study provided the first prospective evidence that fertility-sparing surgery, including conization or simple hysterectomy, was safe in low-risk cervical cancer, and recurrence rates remained low, although oncologic outcomes were not the primary endpoint. OBJECTIVE: This study aimed to examine temporal trends in 2 fertility-sparing procedures for cervical cancer (trachelectomy and conization) along with associated oncologic outcomes and patterns of academic productivity via 3 separate datasets. STUDY DESIGN: This was a retrospective study of 3 separate database, integrating clinical data from the National Cancer Database (2004-2022; for oncologic outcomes and surgical trends), perioperative outcomes from the American College of Surgeons National Surgical Quality Improvement Program Participant Use Data Files (2012-2022; for postoperative complications), and scholarly output from the Web of Science Core Collection (2000-2025; for bibliometric analysis). In the National Cancer Database, we identified two cohorts of patients aged 18 to 45 years with cervical cancer, irrespective of histologic subtype, who were managed with conservative surgery and nodal staging: the first cohort underwent trachelectomy (radicality not specified), whereas the second cohort underwent conization. Temporal trends were examined using annual procedure counts, proportional utilization, and annual percentage change. Clinicopathologic characteristics were descriptively summarized and compared using appropriate parametric or nonparametric tests and chi-squared tests, with Bonferroni correction for multiple comparisons. Overall survival was analyzed in node-negative cases using Kaplan-Meier and log-rank methods, and treatment effects were evaluated with multivariate Cox regression adjusted for stage, histology, surgical margins, and tumor size, reporting hazard ratios with 95% confidence intervals. RESULTS: A total of 1841 patients underwent conservative surgery with lymph node assessment, including 911 trachelectomies (49.5%) and 930 conizations (50.5%). Patients who underwent trachelectomy were younger than those who underwent conization (median: 31 vs 33 years, respectively; P<.001). The number of lymph nodes examined was significantly greater in the trachelectomy cohort than in the conization cohort (15 vs 10, respectively; P<.001). Trachelectomy had a lower proportion of squamous cell carcinoma (465/911 [51.0%]) than conizations (570/930 [61.3%]), and adenocarcinoma was more common among patients who underwent trachelectomy (371/911 [40.7%]) than those who underwent conization (327/930 [35.2%]) (P<.001). In absolute numbers, trachelectomy use increased from 2004 to the mid-2010s, peaking in 2016, but subsequently demonstrated a steady and sustained decline through 2022. Among the whole cohort, the proportion of patients treated with trachelectomy declined from 64.0% in 2011 to 33.3% in 2022 (P<.001). The 10-year overall survival was similar between the groups (93.4% vs 92.3%; log-rank P=.39). In Cox regression, trachelectomy was not associated with overall survival (hazard ratio, 1.02 [95% confidence interval, 0.56-1.86]). Bibliometric analysis identified 1585 trachelectomy-related publications, which peaked in 2021 (n=128) and declined thereafter. Original research comprised 58.0% and reviews 15.6% of publications. CONCLUSION: Trachelectomy use has decreased significantly in recent years, and overall survival was high in both cohorts. This alignment of excellent overall survival with changing practice patterns underscores an ongoing transition toward less radical surgery.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Levin G, Gilbert L, Pareja R, et al. Trachelectomy in decline: national trends, outcomes, and academic output across 3 major databases. Am J Obstet Gynecol. 2026. PMID: 41791563. doi:10.1016/j.ajog.2026.02.045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。